I-N-Methyl-DL-Aspartic Acid

Inkcazelo emfutshane:

I-N-Methyl-DL-Aspartic Acid (NMA) yinto ephuma ngokwemvelo ye-amino acid kwizilwanyana kwaye i-homologue ye-L-Glutamic Acid, i-neurotransmitter ebalulekileyo ye-excitatory kwi-mammalian central nervous system. Kuyaphawuleka kwiimpawu zayo ze-neurogenic, oku kuthetha ukuba ikhuthaza ukukhula nokuphuhliswa kweeseli zengqondo. Le nto iphuma kwi-amino acid inendawo kwiprotein synthesis kunye ne-neurotransmitters kwingqondo efana ne-glutamate kunye ne-aspartate. Yinto ephuma kwi-amino acid kunye ne-neurotransmitter evuselelayo. Amanani aphakathi kwe-NMDA anokukhuthaza kakhulu ukukhuselwa kwe-hormon yokukhula kwezilwanyana (GH) kunye nokwandisa izinga le-GH egazini. Ukongeza, i-N-methyl-DL-aspartic acid inokukhuthaza ukukhula kwe-skeletal muscl*e kwaye yandise ubunzima bemisipha kunye namandla.

I-N-Methyl-DL-Aspartic Acid (NMDA) yi-amino acid ephuma ngokwemvelo kwizilwanyana, kwaye ibalulekile i-neurotransmitter ye-L-glutamic acid homologue kwi-mammalian central nervous system. i-neurotransmitter kwinkqubo ye-nervous central mammalian. Kufanelekile ukukhankanya ukuba ineempawu ze-neurogenic, oku kuthetha ukuba ikhuthaza ukukhula kunye nophuhliso lweeseli zengqondo. Le nto iphuma kwi-amino acid idlala indima ebalulekileyo ekudityanisweni kweeproteni kunye nolawulo lwee-neurotransmitters ebuchosheni, njenge-glutamate kunye ne-aspartate. Yinto ephuma kwi-amino acid kunye ne-neurotransmitter evuselelayo. Umlinganiselo ofanelekileyo we-NMDA unokuchaphazela inkqubo ye-endocrine yomzimba, ngokukodwa ukukhuthaza ukukhutshwa kwe-hormone yokukhula kwezilwanyana (GH), ukwandisa izinga le-GH egazini. Ukongeza, i-N-methyl-DL-aspartic acid inokukhuthaza ukukhula kwemisipha kunye nokwandisa ubunzima bemisipha kunye namandla. I-N-methyl-DL-aspartic acid inokuphucula ukugonywa kunye nokuphucula ukuxhathisa komzimba kunye nokusebenza komzimba.

 


  • FOB ixabiso:US 5 - 2000 / KG
  • Min.Ubungakanani boMyalelo:1KG
  • Ukubonelela ngezakhono:I-10000 KG / ngenyanga
  • Izibuko:eShanghai / eBeijing
  • Immimiselo yokuhlawula:L/C,D/A,D/P,T/T,O/A
  • Imigaqo yokuthumela ngenqanawe:Ngolwandle/Ngomoya/ngeCourier
  • I-imeyile:: info@trbextract.com
  • Iinkcukacha zeMveliso

    Iithegi zeMveliso

    Igama lemveliso:I-N-Methyl-DL-Aspartic Acid

    Inombolo yeCAS:17833-53-3

    Elinye Igama:N-methyl-D,L-aspartate;

    N-methyl-D, L-aspartic acid;

    L-Aspartic acid, N-methyl;

    I-DL-Aspartic acid, i-N-methyl;

    I-DL-2-METHYLAMINOSUCCINIC ACID;

    Iinkcukacha: 98.0%

    Umbala: Umgubo omhlophe onevumba elibonakalayo kunye nencasa

    Isimo se-GMO:GMO Mahala

    Ukupakisha: kwi-25kgs fiber drums

    Ugcino: Gcina isikhongozeli singavulwanga kwindawo epholileyo neyomileyo, Zigcine kude nokukhanya okuqinileyo

    Ubomi beShelf: iinyanga ezingama-24 ukusuka kumhla wokuvelisa

     

    I-N-Methyl-DL-Aspartic Acid (NMA) |NMDAI-Receptor agonist yoPhando lweNeuroscience
    IKhowudi yeMveliso: NMA-2025 | I-CAS:17833-53-3| Ubunyulu: ≥98%

    Product Overview

    I-N-Methyl-DL-Aspartic Acid (NMA), eyaziwa ngokuba yi-DL-2-Methylaminosuccinic Acid, i-analogue ye-glutamate yokwenziwa kunye ne-NMDA enamandla ye-receptor agonist. Isetyenziswa ngokubanzi kuphando lwe-neurobiological ukufunda iplastiki ye-synaptic, i-neuronal excitotoxicity, kunye nemizekelo yezifo ezinjengeentlungu ze-neuropathic kunye nokuwohloka kweretina.

    Ezona mpawu

    • Ubunyulu obuPhezulu: Kuvavanywa ngokungqongqo nge-HPLC (≥98% ukucoceka) ukuqinisekisa ukuhambelana kwiziphumo zovavanyo.
    • Usetyenziso oluguquguqukayo: Ilungelei-In vitrokwayekwi vivoizifundo, kubandakanywa i-fictive locomotion induction kuthungelwano lwe-spinal cord, i-maternal behaviour ye-neural circuitry analysis, kunye ne-retinal damage modeling.
    • UkuThotyelwa kweMigangatho yeHlabathi: Kufunyenwe kumaziko aqinisekisiweyo e-ISO, anokulandeleka ngokupheleleyo kunye namaxwebhu e-MSDS.

    Izicelo kuPhando

    1. I-Neuropharmacology:
      • Ikhupha i-fictive locomotion kwiintambo zomqolo ezizimeleyo xa zidibene kunye ne-5-HT (umzekelo, i-10 µM NMA + 10 µM 5-HT) .
      • Iququzelela ukusebenza kwe-NMDA receptor kwizifundo ze-excitotoxicity kunye neuroprotection.
    2. I-Neuroscience yokuziphatha:
      • Isetyenziswa kwizilonda ze-excitotoxic (umzekelo, ukukhutshwa kwe-MPOA) ukuphanda iindlela zokuziphatha komama.
    3. Umzekelo weSifo:
      • Ibangela ukwehla kweeseli zeretina kwiimodeli zezilwanyana zokufunda ukuphazamiseka kwe-neurodeergenerative.

    IiNgcaciso zobuGcisa

    Ipharamitha Iinkcukacha
    Ifomula yeemolekyuli C₅H₉NO₄
    Ubunzima beMolekyuli 147.13 g/mol
    Izithethantonye I-DL-2-Methylaminosuccinic Acid, i-NMA
    Ugcino Gcina kwi -20 ° C kwiimeko ezomileyo
    IiKhetho zokuPakisha 10 mg, 50 mg, 100 mg (Inokwenzeka ngokwezifiso)

    Kutheni Khetha Thina?

    • Iminyaka eyi-15+ yobuNgcali: Njengomthengisi othembekileyo kwiikhemikhali zophando, sibeka phambili impendulo ekhawulezayo kunye nezisombululo ezilungiselelwe abathengi bezemfundo kunye namashishini.
    • Ukufikeleleka: Iinkcazo zeMveliso zakhiwe ngamagama angundoqo (I-agonist ye-NMDA, ikhemikhali yophando lwe-neuroscience) ukuphucula ukubonakala kuGoogle kunye nogcino lweenkcukacha zenzululwazi.

    Iimveliso ezinxulumeneyo

    • I-5-Hydroxytryptamine (5-HT): Ukusetyenziswa kwe-Synergistic kunye ne-NMA kwizifundo ze-locomotion.
    • I-Calcium 2AEP kunye ne-Astaxanthin: Phonononga ipotifoliyo yethu ye-neuroprotective compound.

  • Ngaphambili:
  • Okulandelayo: